Press release
Multiple Myeloma Market Share, Size, Growth & Global Forcast
American Society of Clinical Oncology (ASCO) projects that approximately 35,730 adults in the United States, comprising 19,860 men and 15,870 women, will receive a multiple myeloma diagnosis in 2023, with an estimated 12,590 deaths, including 7,000 men and 5,590 women, resulting from the disease in the same year. The aging population worldwide has also contributed to the development of this market. The United Nations Population Division's new world population report estimates that the number of people aged 80 or over is projected to triple, from 157 million in 2022 to 459 million in 2050.
Moreover, the availability of advanced diagnostics tools and the development of novel therapies have improved the survival rate of multiple myeloma patients, leading to increased demand for these treatments. For instance, Takeda carried out Phase I/Phase II multicenter trials in December 2022 to examine the safety, efficacy, tolerability, and immunogenicity of Modakafusp Alfa in patients with relapsed or refractory multiple myeloma. Additionally, the increasing adoption of targeted therapies and the use of combination therapies have also contributed to the growth of the multiple myeloma market.
Furthermore, the rising investments in research and development activities by pharmaceutical companies and academic institutions have resulted in the development of more effective and efficient treatments for multiple myeloma. For example, in March 2022, Sanofi entered into a strategic collaboration with Blackstone on a risk-sharing basis. As per the collaboration, Blackstone Life Sciences would invest up to EUR 300 million (USD 320.51 million) to expedite the pivotal global studies and clinical development program for Sarclisa, an anti-CD38 antibody, for treating multiple myeloma patients via subcutaneous formulation and delivery. Lastly, the increasing awareness about multiple myeloma and the availability of treatment options among patients and healthcare professionals have also contributed to the growth of the multiple myeloma market.
Targeted Therapy dominance in the multiple myeloma market due to Selective Cancer Cell Targeting and Personalized Treatment Plans with practical outcomes
The reason for the dominance of targeted therapy in the multiple myeloma market is its ability to selectively target cancer cells while sparing healthy cells, resulting in fewer side effects and better outcomes for patients. Additionally, targeted therapies can be customized to a patient's specific cancer type and genetic profile, allowing personalized treatment plans.
Another factor contributing to the dominance of targeted therapy in the multiple myeloma market is its effectiveness in treating multiple myeloma, with many targeted therapies showing high response rates and improved survival rates in clinical trials. Finally, the approval of several new targeted therapies for multiple myeloma in recent years has expanded treatment options for patients, further contributing to the growth and dominance of this market segment.
Aging Population of Females is increasing the prevalence of Multiple Myeloma in Women, benefiting the multiple myeloma market
The growth of female patients in the multiple myeloma market can be due to increased awareness and early disease diagnosis among women, leading to better detection and treatment. Moreover, as the population ages, more women are developing multiple myeloma, and the risk of the disease increases with age. Furthermore, an increasing number of clinical trials are focusing on the study of multiple myeloma in female patients, which is helping to improve our knowledge of the disease and provide more efficient treatment alternatives for women.
๐ญ๐๐ ๐ด๐๐๐ ๐ซ๐๐๐๐๐๐, ๐ฎ๐๐๐ ๐๐๐ Free Sample Report: https://www.renub.com/request-sample-page.php?gturl=multiple-myeloma-market-p.php
France robust Healthcare System and Favorable Regulatory Environment contributed to its growing Epidemiology Share in the Multiple Myeloma Market
France robust healthcare system strongly emphasizes cancer screening and early detection, resulting in the identification and reporting of more multiple myeloma cases, which played a significant role in the growth of France's epidemiology share in the multiple myeloma market. The country also has an intense research and development infrastructure for cancer treatments, which can lead to better treatment outcomes and longer survival rates for multiple myeloma patients attracting more patients to seek treatment in France, contributing to the country's epidemiology share.
In addition, France has a favorable regulatory environment for clinical trials, which can attract pharmaceutical companies to conduct tests in the country leading to more innovative treatments becoming available in France, further contributing to the country's epidemiology share.
United States (U.S.) has the Lion's Share in the Multiple Myeloma Market
The U.S. has a large patient population with multiple myeloma, which makes it an attractive market for pharmaceutical companies to invest in and develop new treatments. According to the American Cancer Society, approximately 35,730 individuals shall receive a new diagnosis of multiple myeloma in the United States in 2023, with an estimated 12,590 deaths to occur as a result of the disease. Therefore, conducting clinical trials and studies on a larger patient population provides an opportunity for more comprehensive data and evidence on treatment effectiveness.
The U.S. has a favorable regulatory environment for clinical trials and drug approvals, encouraging pharmaceutical companies to conduct studies and bring products to market quickly. In addition, a stable economy provides a conducive environment for investments in research and development, making the U.S. an attractive market for stakeholders in the multiple myeloma market.
Market Summary:
โข Treatment Types- The Report covers the Multiple Myeloma Market by treatment types from 3 viewpoints (Targeted therapy, Chemotherapy, and Others).
โข Gender share- The Multiple Myeloma Market, by gender share, break up into 2 viewpoints (Male and Female).
โข Epidemiology Share-By Epidemiology share, the Multiple Myeloma Market is broken up into 10 viewpoints (United States, United Kingdom, Germany, France, Spain, Italy, Japan, Australia, China, and Australia).
โข Countries- By countries, the Multiple Myeloma Market breaks up into 10 viewpoints (United States, United Kingdom, Germany, France, Spain, Italy, Japan, Australia, China, and Saudi Arabia).
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Contact Us:
Renub Research
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: info@renub.com
LinkedIn: https://in.linkedin.com/company/renub-research
Web: www.renub.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiple Myeloma Market Share, Size, Growth & Global Forcast here
News-ID: 3052615 • Views: โฆ
More Releases from Renub Resaecrh
Global Sports Medicine Market to Hit $12.32 Billion by 2033, Driven by Rising At โฆ
Sports Medicine Market Overview
The growing awareness of injury prevention, increased involvement in sports and physical activities, and advancements in medical technology are all contributing to the notable rise of the global sports medicine industry. The prevention, diagnosis, treatment, and rehabilitation of sports-related injuries are the primary goals of this specialized discipline, which serves athletes, fitness enthusiasts, and individuals who lead active lifestyles. The adoption of less invasive surgical procedures, theโฆ
U.S. Cosmetics Industry Set to Surge Past $149 Billion by 2033 Amid Rising Deman โฆ
United States Cosmetics Market Overview
According to Renub Research, with an absolute compound annual growth rate (CAGR) of 4.82% from 2025 to 2033, the United States cosmetics industry is expected to reach around US$ 149.53 billion in 2033, up from US$ 97.89 billion in 2024.
Growing consumer awareness of personal grooming and beauty improvement, particularly among millennial and Gen Z, is the primary factor driving the US industry. For example, according toโฆ
Global Non-Invasive Prenatal Testing Market to Triple by 2033, Surging to US$ 11 โฆ
Non-Invasive Prenatal Testing Market Overview
A type of prenatal screening called non-invasive prenatal testing (NIPT) uses a pregnant woman's blood sample to check for fetal abnormalities. By examining DNA fragments in the mother's blood, the test is primarily used to identify genetic abnormalities, such as Turner syndrome, Patau syndrome, Edwards syndrome, and Down syndrome. The treatment, which may be carried out after nine weeks of pregnancy, removes the needโฆ
Renub Research: Global Tractor Market Set to Plough Ahead, Reaching $111.22 Bill โฆ
Agricultural Tractors Market Overview
The growing need for automated solutions in contemporary farming is driving the rapid evolution of the agricultural tractor market. Precision agriculture, less manual work, and increased output are all made possible by tractors. To maximize field operations, farmers are implementing tractors equipped with cutting-edge technology, such as automation, telematics, and GPS, as the global demand for food increases. Trends such as climate change adaptation and sustainableโฆ
More Releases for Multiple
Mango AI's Multiple Face Swap Video Tool Changes Multiple Faces Instantly
In today's digital world, creating eye-catching and unique content is essential for standing out. The ability to swap multiple faces in a single video opens up creative possibilities, whether for personalized content, comedy or parody videos, or engaging social media posts. Mango AI, developed by Mango Animate, is excited to announce the launch of its advanced multiple face swap video (https://mangoanimate.com/ai/multiple-face-swap-video) tool, which is designed to simplify the creation ofโฆ
Multiple Sclerosis Drugs Market
Global Multiple Sclerosis Drugs Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.
Get a Sample Copy of the Report at - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100386
Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as progressive brain and spinal cord atrophy and neuroaxonalโฆ
Massive Multiple Input Multiple Output (MIMO) Market May Set New Growth Story
A Latest intelligence report published by MR Forecast with title "Global Massive Multiple Input Multiple Output (MIMO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Massive Multiple Input Multiple Output (MIMO) market. This report provides a detailed overview of key factors in the Global Massive Multiple Input Multiple Output (MIMO) Market and factors such as driver, restraint, past and current trends,โฆ
Multiple Sclerosis Drugs Market - Progressing Towards a Cure: Advancing Multiple โฆ
Newark, New Castle, USA: The "Multiple Sclerosis Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiple Sclerosis Drugs Market: https://www.growthplusreports.com/report/multiple-sclerosis-drugs-market/7983
This latest report researches the industry structure,โฆ
Multiple Sclerosis Drugs Market - Empowering Resilience, Embracing Possibilities โฆ
Newark, New Castle, USA - new report, titled Multiple Sclerosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Multiple Sclerosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Multiple Sclerosis Drugs market. The report offers an overview ofโฆ
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)โฆ
